Log In
BCIQ
Print this Print this
 

Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

BCIQ
Print ChartPrint this
0 0 0 0 1 0 0 0 0 0 0 2 0 0 1 0 0 0 0 0 1 9 12 5 14 2 9 1 2 5
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cancer

1

9

12

5

14

2

9

1

2

5

Ophthalmic

0

2

0

0

1

0

0

0

0

0

Renal

0

0

0

0

1

0

0

0

0

0




 Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

22

$17,747.3M

$14,741.3M

$2,826.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today